Baseline characteristics of patients with premature and non-premature ASCVD
| Characteristics | Patients with premature ASCVD (n=135 703) | Patients with non-premature ASCVD (n=1 112 455) | P value |
| Demographics | |||
| Age, mean (SD) | 49.63 (5.79) | 69.58 (8.92) | <0.01 |
| Men, n (%) | 116 739 (86.1%) | 1 104 318 (99.3%) | <0.01 |
| Race, n (%) | |||
| Asian, n (%) | 967 (0.7%) | 4898 (0.4%) | <0.01 |
| African American, n (%) | 34 008 (25.1%) | 110 516 (9.9%) | <0.01 |
| White, n (%) | 90 835 (66.9%) | 891 800 (80.2%) | <0.01 |
| Medical history | |||
| BMI >30 kg/m2, n (%) | 75 519 (55.8%) | 442 891 (39.9%) | <0.01 |
| Hypertension, n (%) | 127 519 (94.0%) | 1 064 670 (95.7%) | <0.01 |
| Diabetes mellitus, n (%) | 65 263 (48.1%) | 565 444 (50.8%) | <0.01 |
| Hypercholesterolaemia, n (%) | 64 320 (47.4%) | 327 161 (29.4%) | <0.01 |
| Ischaemic heart disease, n (%) | 105 659 (77.9%) | 884 063 (79.5%) | <0.01 |
| Myocardial infarction, n (%) | 64 371 (47.4%) | 278 025 (25.0%) | <0.01 |
| Ischaemic cerebrovascular disease, n (%) | 38 275 (28.2%) | 311 168 (28.0%) | 0.07 |
| Peripheral arterial disease, n (%) | 16 890 (12.5%) | 178 859 (16.1%) | <0.01 |
| Overall health status and healthcare uUtilisation | |||
| Diagnostic Cost Group Relative Risk Score, mean (SD) | 2.18 (2.59) | 1.54 (2.13) | <0.01 |
ASCVD, atherosclerotic cardiovascular disease; BMI, body mass index.